AbbVie (NYSE: ABBV) today announced 20 winners of the inaugural AbbVie Migraine Career Catalyst Award™ contest, a first-of-its-kind contest designed to support the career aspirations of people living ...
Zacks.com on MSN10h
Pharma Stock Roundup: AZN, BAYRY's Earnings, ABBV's Pipeline SetbackThe third-quarter earnings season came to an end this week for large drugmakers, with AstraZeneca AZN and Bayer BAYRY ...
3monon MSN
Strategists at Wells Fargo Investment Institute see the fed funds rate dropping a total of one percentage point this year and ...
Why one trial participant's healthy birth after her CAR-T treatment for lupus is catching resesarchers' attention: ...
Most U.S. stocks rose on Wall Street, but drops for Nvidia and some other heavyweight Big Tech companies kept indexes in ...
U.S. stocks rose Monday, led by those seen as benefiting the most from Donald Trump's reelection as president, but drops for ...
U.S. stocks are rising and adding to the gains made during their best week of the year. The S&P 500 added 0.1% in Monday ...
Markets have been performing well since Wednesday, when Donald Trump won the U.S. presidential election, leading Republicans ...
Irish goods exports to the US last year were valued at €54 billion, accounting for close to one third of the State’s total goods exports. They also accounted for one-eighth of the EU’s total exports ...
On STAT's podcast, hear about what happened with AbbVie's schizophrenia drug, Amgen's obesity drug and what might happen at ...
Wolfe Research initiated coverage of AbbVie (ABBV) with an Outperform rating and $205 price target The firm noted that AbbVie sounded ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback